Aprea Therapeutics
在场
Aprea Therapeutics 是一家在股票代码 APRE (SE) 下上市的公司。
高管
药店
Aprea Therapeutics 拥有 1,833 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Roche (瑞士)。
Popular M&A news in 药店
- Knight Therapeutics has announced the acquisition of Paladin Labs (公布2025三月12号).
- Jazz Pharmaceuticals 已收购 Chimerix (公布2025三月6号).
- Cosette Pharmaceuticals has announced the acquisition of Mayne Pharma (公布2025二月25号).
药店 行业的其他推荐联系人
消息
Aprea Therapeutics 的最新新闻稿
- Aprea Therapeutics Announces Agreement with MD Anderson Cancer Center to Explore APR-1051 as a Potential Treatment for Head and Neck Squamous Cell Carcinoma (HNSCC) | Aprea Therapeutics
- Aprea Therapeutics Announces Strategic IP Portfolio Evolution in DNA Damage Response (DDR) Cancer Therapeutics | Aprea Therapeutics
- Aprea Therapeutics Announces Twice Daily (BID) Dosing of Patients in ABOYA-119 Clinical Trial of ATRN-119 to Potentially Optimize Clinical Outcomes and Strengthen Clinical Path Forward | Aprea Therapeutics
- Aprea Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update | Aprea Therapeutics
- Aprea Therapeutics Presents Preliminary Findings on Oral WEE1 Inhibitor APR-1051 at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics | Aprea Therapeutics
- Aprea Therapeutics to Present at Maxim 2024 Healthcare Virtual Summit | Aprea Therapeutics
- Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics | Aprea Therapeutics
- Aprea Therapeutics Engages Philippe Pultar, MD to Serve as Senior Medical Advisor and Lead WEE1 Clinical Development | Aprea Therapeutics
- Press Releases | Aprea Therapeutics
- Aprea Therapeutics to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 | Aprea Therapeutics
- View more press releases Close
